Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MLYS | AMGN | VRTX | REGN | GILD |
| Company | Mineralys Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 12.41 | 311.36 | 473.00 | 1,039.51 | 67.86 |
| High | 12.65 | 315.48 | 483.00 | 1,054.59 | 68.18 |
| Low | 12.18 | 310.61 | 471.82 | 1,037.32 | 67.03 |
| Last | 12.55 | 311.46 | 481.89 | 1,052.25 | 67.55 |
| Change | +0.12 | +0.58 | +7.32 | +18.02 | +0.86 |
| % Change | +0.97% | +0.19% | +1.54% | +1.74% | +1.29% |
| Volume | 152,500 | 1,167,200 | 774,500 | 366,200 | 5,746,900 |
| 20-Day Average Volume | 296,880 | 2,329,060 | 1,220,890 | 476,070 | 9,084,480 |
| Previous Close | 12.43 | 310.88 | 474.57 | 1,034.23 | 66.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.29 | 308.29 | 475.01 | 1,040.32 | 66.97 |
| 20-Day Raw Stochastic | 57.41% | 52.43% | 80.45% | 67.49% | 51.24% |
| 20-Day Relative Strength | 50.99% | 56.21% | 63.72% | 60.83% | 51.73% |
| Weighted Alpha | -4.67 | +32.63 | +40.32 | +44.39 | -13.96 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 8% Buy | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Last Month's Opinion | 88% Buy | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.26% since 06/28/24 | -0.32% since 06/28/24 | +2.81% since 06/28/24 | +0.12% since 06/28/24 | -1.54% since 06/28/24 |
| Low | 11.73 on 07/01/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 12.65 on 07/08/24 | 319.00 on 07/01/24 | 483.00 on 07/08/24 | 1,069.69 on 07/01/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | -4.49% since 06/07/24 | +2.11% since 06/07/24 | -0.24% since 06/07/24 | +4.92% since 06/07/24 | +4.40% since 06/07/24 |
| Low | 11.04 on 06/26/24 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 992.22 on 06/10/24 | 62.69 on 06/18/24 |
| High | 13.67 on 06/10/24 | 326.12 on 06/25/24 | 485.40 on 06/10/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -5.35% since 04/08/24 | +15.70% since 04/08/24 | +19.21% since 04/08/24 | +12.12% since 04/08/24 | -2.69% since 04/08/24 |
| Low | 10.37 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 15.00 on 05/09/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | +37.61% since 01/08/24 | +0.19% since 01/08/24 | +14.98% since 01/08/24 | +16.54% since 01/08/24 | -19.57% since 01/08/24 |
| Low | 7.95 on 01/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 16.91 on 02/27/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 617,137 | 166,766,912 | 122,464,224 | 113,957,648 | 83,085,936 |
| Shares Outstanding, K | 49,649 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -71,900,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -31,510,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.97 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.70 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/05/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 31.23 | 27.60 | 16.52 |